Publications by authors named "Kate Orroth"

Claim this Profile
B
Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study.
April Armstrong, Bruce Strober, Paolo Gisondi, Kate K Orroth, Myriam Cordey

Dermatol Ther (Heidelb)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Negative Control Outcomes to Assess Comparability of Treatments for Psoriasis and Psoriatic Arthritis.
Mary E Horner, Alexis Ogdie, Kate K Orroth, Shia T Kent, Kathy V Tran

Pharmacoepidemiol Drug Saf· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of Apolipoprotein B Levels Among Hispanic or Latino Individuals Residing in the US.
Leandro Slipczuk, Toshiki Kuno, Santica Marcovina, Katrina Swett, Kate K Orroth

JAMA Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world setting.
Cristi Cavanaugh, Kate Orroth, Xi Qian, Pam Kumparatana, Yuri Klyachkin

JAAD Int· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining Disease Severity with Special Area Involvement and Reflecting on Treatment Patterns in a Real-World Psoriasis Population.
Mary E Horner, Kate K Orroth, Junjie Ma, Yinkang Duan, Myriam Cordey

Dermatol Ther (Heidelb)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.
Ashis K Das, Eunice Chang, Caleb Paydar, Michael S Broder, Kate K Orroth

Dermatol Ther (Heidelb)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.
Ashis K Das, Eunice Chang, Caleb Paydar, Michael S Broder, Kate K Orroth

Dermatol Ther (Heidelb)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of Lipoprotein(a) Levels Among Hispanic or Latino Individuals Residing in the US.
Parag H Joshi, Santica Marcovina, Kate Orroth, J Antonio G López, Shia T Kent

JAMA Cardiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
Emily C McKinley, Vera A Bittner, Todd M Brown, Ligong Chen, Jason Exter, Kate K Orroth

Cardiovasc Drugs Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019.
Alexander R Zheutlin, Catherine G Derington, Jennifer S Herrick, Robert S Rosenson, Bharat Poudel, Kate Orroth

Circ Cardiovasc Qual Outcomes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.
Paul Muntner, Kate K Orroth, Katherine E Mues, Jason Exter, Erin D Shannon

Cardiovasc Drugs Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies.
Sara N Levintow, Kate K Orroth, Alexander Breskin, Andrew S Park, Jose H Flores-Arredondo

Pharmacoepidemiol Drug Saf· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of patients with diabetes and a history of myocardial infarction initiating PCSK9 and SGLT2 inhibitors.
Demetria Hubbard, Emily C McKinley, Lisandro D Colantonio, Bharat Poudel, Robert S Rosenson, Kate K Orroth

Am Heart J Plus· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.
Connie N Hess, Christopher P Cannon, Joshua A Beckman, Philip P Goodney, Manesh R Patel, Kate K Orroth

J Am Coll Cardiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.
Demetria Hubbard, Lisandro D Colantonio, Robert S Rosenson, Todd M Brown, Elizabeth A Jackson, Kate K Orroth

Cardiovasc Diabetol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic Event Rates in Very-High-Risk Adults.
Lisandro D Colantonio, Erin D Shannon, Kate K Orroth, Rebecca Zaha, Elizabeth A Jackson

J Am Coll Cardiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Public and Global Health Education among Nationally Recognized Undergraduate Liberal Arts Colleges in the United States.
Patrick A Robinson, Kate K Orroth, Lauren A Stutts, Patrick A Baron, David R Wessner

Am J Trop Med Hyg· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement.
Richard G White, Avi J Hakim, Matthew J Salganik, Michael W Spiller, Lisa G Johnston, Kate Orroth

J Clin Epidemiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision.
Kate K Orroth, Richard G White, Esther E Freeman, Roel Bakker, Anne Buvé

Sex Transm Infect· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.
Esther E Freeman, Richard G White, Roel Bakker, Kate K Orroth, Helen A Weiss

Vaccine· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
Richard G White, Judith R Glynn, Kate K Orroth, Esther E Freeman, Roel Bakker

AIDS· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?
Richard G White, Kate K Orroth, Judith R Glynn, Esther E Freeman, Roel Bakker

J Acquir Immune Defic Syndr· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study.
Kate K Orroth, Esther E Freeman, Roel Bakker, Anne Buvé, Judith R Glynn

Sex Transm Infect· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.
Esther E Freeman, Kate K Orroth, Richard G White, Judith R Glynn, Roel Bakker

Sex Transm Infect· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying HIV-1 transmission due to contaminated injections.
Richard G White, S Cooper Ben, Anusha Kedhar, Kate K Orroth, Sam Biraro

Proc Natl Acad Sci U S A· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis